Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration

Description of the granted funding

The delivery of therapeutic agents to the central nervous system remains a major challenge. This is especially true in neurodegenerative diseases. While significant discoveries have recently been made in the genetics of ALS/FTD, patients still have no real therapeutic treatments. Here we aim to boost the clinical translation of the preclinical research and assembled a multidisciplinary research team with complimentary expertise to (1) generate 3D in vitro multicellular organoid models from iPSCs derived from healthy and patients with ALS/FTD; (2) fully characterize the newly generated models using established assays in the consortium (e.g. molecular markers and electrophysiology); (3) explore mechanistic pathways in particular pro-inflammatory, anti-oxidant and DNA damage pathways and ultimately use the model for (4) drug and gene based therapeutic screening.
Show more

Starting year

2020

End year

2023

Granted funding

Tarja Malm Orcid -palvelun logo
150 917 €

Funder

Research Council of Finland

Funding instrument

Kansainvälinen yhteisrahoitteinen ohjelma

Other information

Funding decision number

334801

Fields of science

Neurosciences

Research fields

Neurotiede

Identified topics

brain, neuroscience